Physician profile
Gene E Jones
NPI 1134128119
$2,184.58
in general payments reported to CMS, 2019-2025
25 companies · $191 in 2025
The $191 reported for 2025 was more than what a typical Gynecology provider received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $544 · 2020: $334 · 2021: $454 · 2022: $255 · 2023: $285 · 2024: $122 · 2025: $191.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $498 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $498.06 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $375.56 | 2019-2023 | |
| Daiichi Sankyo INC. | $277.51 | 2019-2022 | |
| Astellas Pharma US INC | $246.14 | 2019-2024 | Veozah |
| Takeda Pharmaceuticals U.S.A., INC. | $161.60 | 2020-2022 | |
| Mayne Pharma Commercial LLC | $146.44 | 2021-2025 | |
| Exeltis, USA INC. | $131.87 | 2021-2025 | Slynd |
| Radius Health, INC. | $107.18 | 2019 | |
| Lupin INC. | $100.78 | 2019-2020 | |
| Amgen INC. | $93.22 | 2022-2025 | Evenity, Prolia, Prolia |
| Hologic Sales and Service, LLC | $68.80 | 2019 | |
| Becton, Dickinson and Company | $67.99 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $67.49 | 2019-2022 | |
| Allergan, INC. | $50.02 | 2019-2020 | |
| Millicent US INC | $41.25 | 2025 | Femlyv, Intrarosa |
| Avion Pharmaceuticals | $37.45 | 2020 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $34.38 | 2019-2025 | Axonics |
| Exact Sciences Corporation | $32.99 | 2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Pfizer INC. | $28.80 | 2024 | |
| Axonics, INC. | $23.55 | 2024 | Axonics |
| Aspira Women'S Health INC | $19.49 | 2024 | Ova1 |
| Amag Pharmaceuticals, INC. | $16.23 | 2020 | |
| Vertical Pharmaceuticals, LLC | $15.75 | 2019 | |
| Ascend Therapeutics US, LLC | $14.45 | 2020 | |
| Glaxosmithkline, LLC. | $13.34 | 2020 | |
| Therapeuticsmd, INC. | $12.30 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gene Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.